NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

EMBC

Embecta Corp

Jul 03 • 04:00PM ET

10.32

Dollar change +0.07
Percentage change 0.68	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DXCM PODD TNDM ABT MDT LCTX VTRS BAX BMY MRK

| Held by: IJR VTI VB IWM VBR VXF IJS SPSM IWN SLYV

Scroll to Statements

Index	RUT	P/E	11.38	EPS (ttm)	0.91	Insider Own	6.91%	Shs Outstand	58.33M	Perf Week	11.21%
Market Cap	603.13M	Forward P/E	3.62	EPS next Y	2.85	Insider Trans	0.50%	Shs Float	54.40M	Perf Month	-2.73%
Enterprise Value	1.96B	PEG	1.76	EPS next Q	0.78	Inst Own	93.66%	Short Float	8.12%	Perf Quarter	-17.57%
Income	52.80M	P/S	0.56	EPS this Y	15.51%	Inst Trans	4.18%	Short Ratio	6.68	Perf Half Y	-49.66%
Sales	1.08B	P/B	-	EPS next Y	0.62%	ROA	4.55%	Short Interest	4.42M	Perf YTD	-50.02%
Book/sh	-12.62	P/C	2.84	EPS next 5Y	6.47%	ROE	-	52W High	21.48 -51.96%	Perf Year	-15.06%
Cash/sh	3.63	P/FCF	15.19	EPS past 3/5Y	-43.15% -	ROIC	6.49%	52W Low	9.20 12.17%	Perf 3Y	-61.51%
Dividend Est.	0.60 (5.79%)	EV/EBITDA	7.31	Sales past 3/5Y	-1.21% 0.25%	Gross Margin	62.56%	Volatility	4.68% 4.77%	Perf 5Y	-
Dividend TTM	0.60 (5.81%)	EV/Sales	1.82	EPS Y/Y TTM	-25.40%	Oper. Margin	20.51%	ATR (14)	0.50	Perf 10Y	-
Dividend Ex-Date	May 28, 2025	Quick Ratio	1.83	Sales Y/Y TTM	-4.68%	Profit Margin	4.89%	RSI (14)	50.66	Recom	2.75
Dividend Gr. 3/5Y	- -	Current Ratio	2.48	EPS Q/Q	-19.70%	SMA20	4.07%	Beta	1.02	Target Price	18.67
Payout	44.70%	Debt/Eq	-	Sales Q/Q	-9.82%	SMA50	-6.11%	Rel Volume	0.44	Prev Close	10.25
Employees	2100	LT Debt/Eq	-	Earnings	May 09 BMO	SMA200	-28.95%	Avg Volume	661.60K	Price	10.32
IPO	Mar 22, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	32.58% 2.01%	Trades		Volume	291,940	Change	0.68%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Neutral	$15
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$13 → $20
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy	$26
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

May-27-25 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +5.09% -6.31%
May-22-25 06:30AM	embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day (GlobeNewswire) -14.97%
May-13-25 10:50AM	Embecta restructures again, outlines tariff costs (MedTech Dive)
May-10-25 05:16AM	Q2 2025 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
12:10PM	Loading…
May-09-25 12:10PM	Why Is Embecta Stock Falling On Friday? (Benzinga) -10.00%
07:40AM	Embecta Corp. (EMBC) Tops Q2 Earnings Estimates (Zacks)
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-08-25 05:15PM	Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates (Zacks) +6.66%
May-07-25 11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
Apr-28-25 07:30AM	Embecta to host Analyst and Investor Day on May 22, 2025 (GlobeNewswire)
Apr-22-25 03:51AM	Beyond the drug: Closing the knowledge gap for injectable diabetes meds (Pharma Voice)
Apr-21-25 05:00PM	embecta to Report Fiscal Second Quarter 2025 Financial Results (GlobeNewswire)
Apr-01-25 08:05AM	Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations (GlobeNewswire)
03:36PM	Loading…
Feb-19-25 03:36PM	Embecta Corp. (EMBC): Among Last Weeks Worst Dividend Stocks (Insider Monkey)
Feb-18-25 05:00PM	embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference (GlobeNewswire)
Feb-07-25 02:09AM	Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
Feb-06-25 07:45AM	Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-23-25 05:00PM	embecta to Report Fiscal First Quarter 2025 Financial Results (GlobeNewswire)
Dec-19-24 05:00PM	embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-09-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) (Zacks)
Dec-06-24 06:00AM	Embecta to cut 125 jobs after ending insulin patch pump (MedTech Dive)
Nov-27-24 06:40AM	Embecta to discontinue insulin patch pump program, initiates restructuring plan (TipRanks) +10.11%
02:02AM	Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance (GuruFocus.com)
12:26AM	Q4 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga) +29.77%
07:40AM	Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:40AM	Loading…
06:40AM	Embecta discontinues insulin patch pump development (MedTech Dive)
06:30AM	Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 05:31PM	UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell (GlobeNewswire) -6.37%
Sep-03-24 07:55AM	Embecta gets FDA nod for insulin patch pump (MedTech Dive)
06:30AM	embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes (GlobeNewswire)
Aug-22-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.14%
Aug-12-24 09:35AM	Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average (Zacks)
Aug-10-24 08:18AM	Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace) +7.32%
07:40AM	Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Aug-02-24 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline (Zacks)
Jul-31-24 09:47AM	Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock? (Zacks)
Jul-29-24 08:05AM	Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company (PR Newswire)
Jul-24-24 04:21AM	Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Jul-22-24 07:42AM	Diabetes device firm Embecta considers sale: Financial Times (MedTech Dive) +15.26%
Jul-18-24 05:00PM	embecta to Report Fiscal Third Quarter 2024 Financial Results (GlobeNewswire)
Jun-25-24 07:47AM	Embecta touts its insulin patch pump at ADA (MedTech Dive)
Jun-24-24 06:30AM	embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir (GlobeNewswire)
Jun-20-24 07:30AM	Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors (PR Newswire)
May-21-24 04:30PM	Trade Winds Turning: 3 Stocks Poised to Gain from Biden's China Tariffs (InvestorPlace)
May-13-24 11:52AM	Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 02:12PM	Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024 (GuruFocus.com)
May-09-24 10:54AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +37.88%
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Apr-23-24 05:00PM	embecta to Report Fiscal Second Quarter 2024 Financial Results (GlobeNewswire)
Mar-06-24 06:00AM	embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes (GlobeNewswire)
Feb-10-24 08:55AM	Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-09-24 10:07PM	Q1 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents) -8.47% -7.91%
11:43AM	Why Embecta Stock Is Tanking Today (Motley Fool)
07:45AM	Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:07AM	Embecta Corp (EMBC) Reports Modest Revenue Growth and Decline in Profitability in Q1 Fiscal 2024 (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Feb-07-24 05:00PM	embecta to Participate in the 11th Annual BTIG MedTech Conference (GlobeNewswire)
Jan-24-24 05:00PM	embecta to Report Fiscal First Quarter 2024 Financial Results (GlobeNewswire)
Jan-21-24 08:33AM	16 Most Profitable New Stocks Today (Insider Monkey)
Jan-09-24 06:00AM	embecta Announces FDA 510(k) Submission for Insulin Patch Pump (GlobeNewswire)
Dec-14-23 05:00PM	embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-01-23 06:00AM	No embecta-made syringes impacted by FDA safety communication (GlobeNewswire)
05:13AM	Embecta Corp's Dividend Analysis (GuruFocus.com)
Nov-29-23 05:00PM	embecta to Participate in Investor Conferences (GlobeNewswire)
Nov-22-23 09:34AM	Embecta Corp. (NASDAQ:EMBC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Nov-21-23 07:23AM	Embecta CEO Dev Kurdikar talks about growth expectations, GLP-1s (MedTech Dive)
07:15AM	Embecta Corp. (EMBC) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:13AM	Embecta Corp (EMBC) Posts Mixed Fiscal 2023 Results and Issues Fiscal 2024 Guidance (GuruFocus.com)
05:30AM	Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance (GlobeNewswire)
05:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-14-23 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q4 Earnings Expected to Decline (Zacks) +7.29%
Oct-31-23 06:50AM	embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell (GlobeNewswire)
Oct-25-23 05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) -9.02%
Sep-28-23 08:10PM	7 Contrarian Stocks to Buy for the High-Stakes Gambler (InvestorPlace)
Sep-06-23 05:00PM	embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference (GlobeNewswire) -13.20%
Aug-11-23 06:08AM	Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15 (Simply Wall St.)
Aug-08-23 10:19PM	Q3 2023 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-11-23 05:00PM	embecta to Report Fiscal Third Quarter 2023 Financial Results (GlobeNewswire)
Jun-30-23 06:15AM	The Market Doesn't Like What It Sees From Embecta Corp.'s (NASDAQ:EMBC) Revenues Yet (Simply Wall St.)
Jun-21-23 08:00PM	EMBC: Lowering target price to $26.00 (Argus Research)
May-20-23 08:26AM	Just Four Days Till Embecta Corp. (NASDAQ:EMBC) Will Be Trading Ex-Dividend (Simply Wall St.)
May-15-23 05:38PM	UPDATE -- embecta to Participate in Investor Conferences (GlobeNewswire) -6.45%

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Melcher David F	Director	May 23 '25	Buy	10.60	10,000	105,995	86,681	May 23 04:35 PM
Melcher David F	Director	Feb 25 '25	Buy	13.67	13,000	177,646	76,681	Feb 25 04:26 PM
Morris Milton Mayo	Director	Feb 13 '25	Sale	16.38	3,100	50,783	36,133	Feb 14 06:42 PM
Morris Milton Mayo	Director	Feb 13 '25	Proposed Sale	16.38	3,100	50,778		Feb 13 03:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EMBC

Embecta Corp

Upgrade your FINVIZ experience